\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\:\\ bp\\ 98\\/59\\,\\ pulse\\ 104\\,\\ temp\\ 36\\.8c\\,\\ resp\\ rate\\ 28\\,\\ height\\ 105cm\\,\\ weight\\ 17kg\ \(0\)\
\-\ general\\:\\ awake\\,\\ alert\\,\\ cooperative\\ with\\ exam\\,\\ no\\ acute\\ distress\ \(0\)\
\-\ head\\:\\ diffuse\\ seborrheic\\ dermatitis\\,\\ 3\\.5x4cm\\ scabbed\\ lesion\\ on\\ l\\ frontal\\ scalp\ \(0\)\
\-\ ears\\:\\ tympanic\\ membranes\\ obstructed\\ bilaterally\\ by\\ purulent\\ fluid\\ in\\ external\\ canals\ \(0\)\
\-\ abdomen\\:\\ distended\\,\\ hepatomegaly\\,\\ hyperactive\\ bowel\\ sounds\ \(0\)\
\-\ neuro\\:\\ no\\ focal\\ deficits\\,\\ cn\\ 2\\-12\\ grossly\\ intact\\,\\ reflexes\\ 2\\+\\ bilaterally\ \(0\)\
\-\ remainder\\ of\\ physical\\ exam\\ reassuring\\ and\\ without\\ abnormalities\ \(0\)\
\-\ bmp\\:\\ na\\ 143\\|k\\ 3\\.3\\|cl\\ 109\\|co2\\ 25\\|bun\\ 5\\|cr\\ 0\\.3\\|glu\\ 80\ \(0\)\
\-\ serum\\ osmolality\\:\\ 286\ \(0\)\
\-\ urine\\ sodium\\:\\ 11\ \(0\)\
\-\ urine\\ osmolality\\:\\ 41\ \(0\)\
\-\ concurrent\\ diabetes\\ insipidus\\ treated\\ with\\ vasopressin\\ and\\ followed\\ by\\ endocrinology\ \(0\)\
\-\ vinblastine\\,\\ prednisone\\ managed\\ by\\ hematology\\/oncology\ \(0\)\
\-\ close\\ follow\\-up\\ with\\ neurosurgery\\ given\\ location\\ of\\ lesion\ \(0\)\
\-\ xr\\ skull\\:\\ \\‚\\Ä\\úpunched\\ out\\‚\\Ä\\ù\\ lytic\\ lesions\\ involving\\ left\\ parietal\\ and\\ temporal\\ bones\ \(0\)\
\-\ ct\\ head\\:\\ large\\ lytic\\ lesion\\ involving\\ left\\ parietal\\,\\ temporal\\,\\ occipital\\,\\ and\\ greater\\ wing\\ of\\ sphenoid\\ bone\\.\\ significant\\ bony\\ destruction\\ involving\\ temporal\\ bone\\ with\\ soft\\ tissue\\ extension\\ into\\ the\\ external\\ auditory\\ canal\\,\\ middle\\ ear\\ cavity\\,\\ left\\ parapharyngeal\\ fat\\,\\ and\\ lateral\\ pterygoid\\ and\\ temporalis\\ musculature\\.\\ second\\ \\(1cm\\)\\ lytic\\ lesion\\ in\\ the\\ right\\ mastoid\\ sinus\\ with\\ erosion\\ of\\ the\\ anterior\\ and\\ inferior\\ wall\\ and\\ extension\\ into\\ the\\ right\\ external\\ auditory\\ canal\\.\\ \ \(0\)\
\-\ mr\\ brain\\:\\ extensive\\ enhancing\\ soft\\ tissue\\ mass\\ with\\ bone\\ destruction\\ throughout\\ left\\ temporal\\ bone\\ with\\ extension\\ to\\ occipital\\ and\\ sphenoid\\ bones\\.\\ additional\\ erosion\\ of\\ left\\ mandibular\\ condyle\\ and\\ right\\ mastoid\\ sinus\\.\\ enhancing\\ mass\\ present\\ at\\ the\\ infundibulum\\.\\ disease\\ extension\\ into\\ the\\ upper\\ neck\\ surrounding\\,\\ but\\ not\\ narrowing\\ the\\ internal\\ carotid\\ artery\\.\\ \ \(0\)\
\-\ us\\ abdomen\\:\\ borderline\\ hepatomegaly\\,\\ no\\ intra\\-abdominal\\ mass\\ identified\\.\\ bilateral\\ extrarenal\\ pelvises\\ without\\ caliectasis\\.\\ kidneys\\ otherwise\\ normal\\ in\\ appearance\\.\\ \ \(0\)\
\-\ xr\\ abdomen\\:\\ prominent\\ hepatic\\ shadow\\.\\ \ \(0\)\
\-\ xr\\ chest\\:\\ no\\ acute\\ pulmonary\\ consolidation\\.\\ \ \(0\)\
\-\ ct\\ chest\\,\\ abdomen\\,\\ pelvis\\:\\ normal\\ study\\.\\ \ \(0\)\
\-\ nuclear\\ bone\\ scan\\:\\ solitary\\ lesion\\ in\\ left\\ temporoparietal\\ cavarium\\.\\ no\\ additional\\ skeletal\\ abnormality\\.\ \(0\)\
\-\ langerhans\\ cell\\ histiocytosis\ \(1\)\
\-\ langerhan\\‚\\Ä\\ôs\\ cell\\ histiocytosis\ \(0\)\
\-\ sarcoidosis\ \(108\)\
\-\ neuroblastoma\ \(81\)\
\-\ osteosarcoma\ \(92\)\
\-\ rhabdomyosarcoma\ \(41\)\
\-\ osteomyelitis\ \(170\)\
\-\ 4\\ year\\ old\\ male\\ with\\ history\\ of\\ non\\-healing\\ lesion\\ on\\ scalp\\ for\\ approximately\\ 12\\ months\\ along\\ with\\ seborrheic\\ changes\\ of\\ scalp\\.\\ lesions\\ were\\ not\\ responsive\\ to\\ griseofulvin\\ or\\ hydrocortisone\\ creams\\.\\ concurrent\\ history\\ of\\ polydipsia\\,\\ polyuria\\,\\ and\\ purulent\\ drainage\\ from\\ bilateral\\ external\\ auditory\\ canals\\.\ \(0\)\
\-\ in\\ this\\ case\\,\\ the\\ patient\\ is\\ near\\ the\\ age\\ range\\ \\(5\\-10\\ years\\ old\\)\\ typically\\ associated\\ with\\ eosinophilic\\ granuloma\\ \\(langerhans\\ cell\\ histiocytosis\\)\\.\\ secondary\\ to\\ intracranial\\ tumor\\ extension\\,\\ this\\ patient\\ was\\ treated\\ for\\ concurrent\\ diabetes\\ insipidus\\ with\\ vasopressin\\.\\ with\\ clinically\\ demonstrated\\ cns\\ involvement\\,\\ there\\ is\\ increased\\ risk\\ for\\ this\\ patient\\ to\\ develop\\ additional\\ cns\\ complications\\.\\ due\\ to\\ temporal\\ bone\\ involvement\\,\\ potential\\ for\\ otitis\\ media\\ refractory\\ to\\ antibiotic\\ treatment\\ and\\ hearing\\ loss\\ in\\ the\\ left\\ ear\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ temporal\\:\\ 0\\.17754003984141106\ \(0\)\
\-\ xr\\:\\ 0\\.1762631964380311\ \(0\)\
\-\ concurrent\\:\\ 0\\.1670378950748585\ \(0\)\
\-\ extension\\:\\ 0\\.16360526769218006\ \(0\)\
\-\ bone\\:\\ 0\\.15132721665979604\ \(0\)\
\-\ external\\:\\ 0\\.14947779727674385\ \(0\)\
\-\ auditory\\:\\ 0\\.14209965715550382\ \(0\)\
\-\ seborrheic\\:\\ 0\\.1412729984289438\ \(0\)\
\-\ osmolality\\:\\ 0\\.1412729984289438\ \(0\)\
\-\ vasopressin\\:\\ 0\\.1412729984289438\ \(0\)\
\-\ scalp\\:\\ 0\\.1407611672246842\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.13908396712493365\ \(0\)\
\-\ lesion\\:\\ 0\\.13296460739817764\ \(0\)\
\-\ insipidus\\:\\ 0\\.12754126039734526\ \(0\)\
\-\ lytic\\:\\ 0\\.11680915997778525\ \(0\)\
\-\ hepatomegaly\\:\\ 0\\.11518963291499296\ \(0\)\
\-\ and\\:\\ 0\\.1146192463507834\ \(0\)\
\-\ abdomen\\:\\ 0\\.11281713853552428\ \(0\)\
\-\ left\\:\\ 0\\.11037587279518007\ \(0\)\
\-\ with\\:\\ 0\\.10861461965544857\ \(0\)\
\-\ canals\\:\\ 0\\.10757251618138804\ \(0\)\
\-\ additional\\:\\ 0\\.10749871050897142\ \(0\)\
\-\ purulent\\:\\ 0\\.10627530354283547\ \(0\)\
\-\ involving\\:\\ 0\\.09713168276873259\ \(0\)\
\-\ langerhans\\:\\ 0\\.09702876475401752\ \(0\)\
\-\ mastoid\\:\\ 0\\.0953565087892435\ \(0\)\
\-\ sphenoid\\:\\ 0\\.09299502941723342\ \(0\)\
\-\ the\\:\\ 0\\.09223343773398425\ \(0\)\
\-\ cns\\:\\ 0\\.08633255212507993\ \(0\)\
\-\ erosion\\:\\ 0\\.08579527067149892\ \(0\)\
\-\ diabetes\\:\\ 0\\.08444394610886989\ \(0\)\
\-\ destruction\\:\\ 0\\.08428268601015916\ \(0\)\
\-\ ear\\:\\ 0\\.0841230147067249\ \(0\)\
\-\ urine\\:\\ 0\\.08275263487299443\ \(0\)\
\-\ cell\\:\\ 0\\.07932660836130549\ \(0\)\
\-\ occipital\\:\\ 0\\.0791070828875707\ \(0\)\
\-\ no\\:\\ 0\\.07515743820085229\ \(0\)\
\-\ parietal\\:\\ 0\\.07465009564245904\ \(0\)\
\-\ bones\\:\\ 0\\.0743865694100588\ \(0\)\
\-\ 105cm\\:\\ 0\\.0739220856096451\ \(0\)\
\-\ 17kg\\:\\ 0\\.0739220856096451\ \(0\)\
\-\ scabbed\\:\\ 0\\.0739220856096451\ \(0\)\
\-\ cavarium\\:\\ 0\\.0739220856096451\ \(0\)\
\-\ creams\\:\\ 0\\.0739220856096451\ \(0\)\
\-\ into\\:\\ 0\\.07371549502453247\ \(0\)\
\-\ of\\:\\ 0\\.07236650746599876\ \(0\)\
\-\ canal\\:\\ 0\\.07115817918328145\ \(0\)\
\-\ pelvises\\:\\ 0\\.0706364992144719\ \(0\)\
\-\ caliectasis\\:\\ 0\\.0706364992144719\ \(0\)\
\-\ griseofulvin\\:\\ 0\\.0706364992144719\ \(0\)\
\-\ to\\:\\ 0\\.06933531134586375\ \(0\)\
\-\ in\\:\\ 0\\.06899404308701777\ \(0\)\
\-\ polydipsia\\:\\ 0\\.0683053385683858\ \(0\)\
\-\ involvement\\:\\ 0\\.06691166390328256\ \(0\)\
\-\ sinus\\:\\ 0\\.06680216006637404\ \(0\)\
\-\ reassuring\\:\\ 0\\.06649714989392898\ \(0\)\
\-\ temporalis\\:\\ 0\\.06649714989392898\ \(0\)\
\-\ hydrocortisone\\:\\ 0\\.06649714989392898\ \(0\)\
\-\ vinblastine\\:\\ 0\\.06501975217321261\ \(0\)\
\-\ temporoparietal\\:\\ 0\\.06501975217321261\ \(0\)\
\-\ 12\\:\\ 0\\.06319669986587234\ \(0\)\
\-\ hyperactive\\:\\ 0\\.06268859152712651\ \(0\)\
\-\ 286\\:\\ 0\\.06268859152712651\ \(0\)\
\-\ extrarenal\\:\\ 0\\.06268859152712651\ \(0\)\
\-\ polyuria\\:\\ 0\\.06268859152712651\ \(0\)\
\-\ bilaterally\\:\\ 0\\.06165602654168771\ \(0\)\
\-\ pterygoid\\:\\ 0\\.06088040285266968\ \(0\)\
\-\ cooperative\\:\\ 0\\.0601080803424845\ \(0\)\
\-\ punched\\:\\ 0\\.05940300513195331\ \(0\)\
\-\ by\\:\\ 0\\.05888805162525223\ \(0\)\
\-\ parapharyngeal\\:\\ 0\\.05815388315741333\ \(0\)\
\-\ enhancing\\:\\ 0\\.057913035219055185\ \(0\)\
\-\ infundibulum\\:\\ 0\\.05759481645749648\ \(0\)\
\-\ treated\\:\\ 0\\.057569862496578555\ \(0\)\
\-\ endocrinology\\:\\ 0\\.05707184448586721\ \(0\)\
\-\ langerhan\\:\\ 0\\.05611741873678012\ \(0\)\
\-\ for\\:\\ 0\\.056040442301407395\ \(0\)\
\-\ dermatitis\\:\\ 0\\.055679298358286174\ \(0\)\
\-\ head\\:\\ 0\\.05513790291885458\ \(0\)\
\-\ sodium\\:\\ 0\\.05378625809069402\ \(0\)\
\-\ 104\\:\\ 0\\.053455467136953545\ \(0\)\
\-\ awake\\:\\ 0\\.053455467136953545\ \(0\)\
\-\ resp\\:\\ 0\\.053137651771417736\ \(0\)\
\-\ lesions\\:\\ 0\\.05309382493588875\ \(0\)\
\-\ mass\\:\\ 0\\.05296889221173542\ \(0\)\
\-\ otitis\\:\\ 0\\.05283183234160693\ \(0\)\
\-\ tympanic\\:\\ 0\\.052537136116154036\ \(0\)\
\-\ bmp\\:\\ 0\\.052537136116154036\ \(0\)\
\-\ responsive\\:\\ 0\\.052537136116154036\ \(0\)\
\-\ obstructed\\:\\ 0\\.05225278227002771\ \(0\)\
\-\ borderline\\:\\ 0\\.05225278227002771\ \(0\)\
\-\ ears\\:\\ 0\\.051712365182721196\ \(0\)\
\-\ media\\:\\ 0\\.05145509744460791\ \(0\)\
\-\ refractory\\:\\ 0\\.050728947441697196\ \(0\)\
\-\ mandibular\\:\\ 0\\.050500671695520825\ \(0\)\
\-\ wing\\:\\ 0\\.05027865087292971\ \(0\)\
\-\ musculature\\:\\ 0\\.05027865087292971\ \(0\)\
\-\ acute\\:\\ 0\\.050010729746847435\ \(0\)\
\-\ bilateral\\:\\ 0\\.049684863528341894\ \(0\)\
\-\ soft\\:\\ 0\\.049217245797112806\ \(0\)\
\-\ 1cm\\:\\ 0\\.04906087614484179\ \(0\)\
\-\ chest\\:\\ 0\\.04879863786178753\ \(0\)\
\-\ without\\:\\ 0\\.0487627430382442\ \(0\)\
\-\ prednisone\\:\\ 0\\.048692483021063986\ \(0\)\
\-\ membranes\\:\\ 0\\.04851438237700876\ \(0\)\
\-\ tissue\\:\\ 0\\.04849603642337321\ \(0\)\
\-\ this\\:\\ 0\\.04765009760674581\ \(0\)\
\-\ shadow\\:\\ 0\\.04721508530034763\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.04677696492185369\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.04677696492185369\ \(0\)\
\-\ exam\\:\\ 0\\.046538272875623704\ \(0\)\
\-\ right\\:\\ 0\\.04597541027347711\ \(0\)\
\-\ temp\\:\\ 0\\.04583835040334862\ \(0\)\
\-\ managed\\:\\ 0\\.045228795981835566\ \(0\)\
\-\ cn\\:\\ 0\\.0451122004004379\ \(0\)\
\-\ patient\\:\\ 0\\.04510294652182135\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.04499725871293359\ \(0\)\
\-\ condyle\\:\\ 0\\.04488392465426153\ \(0\)\
\-\ height\\:\\ 0\\.044339877890252725\ \(0\)\
\-\ grossly\\:\\ 0\\.044339877890252725\ \(0\)\
\-\ na\\:\\ 0\\.043830071239313664\ \(0\)\
\-\ nuclear\\:\\ 0\\.04373184878697521\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.04373184878697521\ \(0\)\
\-\ pulse\\:\\ 0\\.04363480267972154\ \(0\)\
\-\ antibiotic\\:\\ 0\\.04325783921870661\ \(0\)\
\-\ neuro\\:\\ 0\\.04307573597980469\ \(0\)\
\-\ consolidation\\:\\ 0\\.042723365111572854\ \(0\)\
\-\ alert\\:\\ 0\\.042552764008175425\ \(0\)\
\-\ develop\\:\\ 0\\.042552764008175425\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.04246879172198061\ \(0\)\
\-\ 41\\:\\ 0\\.042385680705181554\ \(0\)\
\-\ solitary\\:\\ 0\\.042303413469619515\ \(0\)\
\-\ hearing\\:\\ 0\\.04198245059846933\ \(0\)\
\-\ skeletal\\:\\ 0\\.04190415768889914\ \(0\)\
\-\ close\\:\\ 0\\.0418266140052647\ \(0\)\
\-\ granuloma\\:\\ 0\\.0418266140052647\ \(0\)\
\-\ serum\\:\\ 0\\.041449650544249775\ \(0\)\
\-\ potential\\:\\ 0\\.041303642033635436\ \(0\)\
\-\ vitals\\:\\ 0\\.040812385378822466\ \(0\)\
\-\ remainder\\:\\ 0\\.0406773280340646\ \(0\)\
\-\ reflexes\\:\\ 0\\.04041378437997811\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.03985039709712641\ \(0\)\
\-\ kidneys\\:\\ 0\\.0397901495846315\ \(0\)\
\-\ deficits\\:\\ 0\\.03973034670727634\ \(0\)\
\-\ distended\\:\\ 0\\.0394954533591786\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.039155406832641626\ \(0\)\
\-\ carotid\\:\\ 0\\.03893638665926175\ \(0\)\
\-\ clinically\\:\\ 0\\.038413414687632486\ \(0\)\
\-\ 28\\:\\ 0\\.03836292696603628\ \(0\)\
\-\ cavity\\:\\ 0\\.03816406414907658\ \(0\)\
\-\ normal\\:\\ 0\\.03774582019017838\ \(0\)\
\-\ near\\:\\ 0\\.03764109217744731\ \(0\)\
\-\ bp\\:\\ 0\\.03750413252662574\ \(0\)\
\-\ skull\\:\\ 0\\.03750413252662574\ \(0\)\
\-\ distress\\:\\ 0\\.037236968115954276\ \(0\)\
\-\ intracranial\\:\\ 0\\.0371932847050294\ \(0\)\
\-\ general\\:\\ 0\\.03710661807031356\ \(0\)\
\-\ drainage\\:\\ 0\\.037020868560051455\ \(0\)\
\-\ hepatic\\:\\ 0\\.03681038261926911\ \(0\)\
\-\ us\\:\\ 0\\.03676893366392226\ \(0\)\
\-\ not\\:\\ 0\\.03649619556500144\ \(0\)\
\-\ prominent\\:\\ 0\\.03640513552359753\ \(0\)\
\-\ 80\\:\\ 0\\.036056970860029236\ \(0\)\
\-\ range\\:\\ 0\\.03586982043746844\ \(0\)\
\-\ narrowing\\:\\ 0\\.035832903502990475\ \(0\)\
\-\ sounds\\:\\ 0\\.035686894992376136\ \(0\)\
\-\ bony\\:\\ 0\\.03561486560164069\ \(0\)\
\-\ extensive\\:\\ 0\\.03561486560164069\ \(0\)\
\-\ complications\\:\\ 0\\.03540254114624983\ \(0\)\
\-\ history\\:\\ 0\\.03532041459384009\ \(0\)\
\-\ ct\\:\\ 0\\.03519574854676968\ \(0\)\
\-\ rate\\:\\ 0\\.035027165468741954\ \(0\)\
\-\ 11\\:\\ 0\\.034604856320830026\ \(0\)\
\-\ second\\:\\ 0\\.034604856320830026\ \(0\)\
\-\ greater\\:\\ 0\\.034054234908912996\ \(0\)\
\-\ throughout\\:\\ 0\\.03399530189931697\ \(0\)\
\-\ abnormality\\:\\ 0\\.033622343011204064\ \(0\)\
\-\ abnormalities\\:\\ 0\\.03348334726874906\ \(0\)\
\-\ intact\\:\\ 0\\.03345583195164128\ \(0\)\
\-\ middle\\:\\ 0\\.03305393538448646\ \(0\)\
\-\ risk\\:\\ 0\\.03302783792842687\ \(0\)\
\-\ otherwise\\:\\ 0\\.03295004610119937\ \(0\)\
\-\ identified\\:\\ 0\\.03277138446485603\ \(0\)\
\-\ typically\\:\\ 0\\.032449686371357894\ \(0\)\
\-\ pelvis\\:\\ 0\\.0323292792064675\ \(0\)\
\-\ weight\\:\\ 0\\.03223422529420908\ \(0\)\
\-\ location\\:\\ 0\\.032187113224860134\ \(0\)\
\-\ given\\:\\ 0\\.031797348413469796\ \(0\)\
\-\ inferior\\:\\ 0\\.03144688284811586\ \(0\)\
\-\ followed\\:\\ 0\\.031214439833602663\ \(0\)\
\-\ internal\\:\\ 0\\.03115218662266296\ \(0\)\
\-\ along\\:\\ 0\\.03096824611970095\ \(0\)\
\-\ surrounding\\:\\ 0\\.030828013270843856\ \(0\)\
\-\ study\\:\\ 0\\.030828013270843856\ \(0\)\
\-\ out\\:\\ 0\\.030383623450565327\ \(0\)\
\-\ mr\\:\\ 0\\.029908972962713824\ \(0\)\
\-\ frontal\\:\\ 0\\.02975094134974581\ \(0\)\
\-\ bowel\\:\\ 0\\.029664459706026183\ \(0\)\
\-\ approximately\\:\\ 0\\.02949421703470234\ \(0\)\
\-\ age\\:\\ 0\\.029019824596387016\ \(0\)\
\-\ diffuse\\:\\ 0\\.028988109279570726\ \(0\)\
\-\ brain\\:\\ 0\\.02881585973279182\ \(0\)\
\-\ fat\\:\\ 0\\.028754120362871026\ \(0\)\
\-\ artery\\:\\ 0\\.028708122586933216\ \(0\)\
\-\ demonstrated\\:\\ 0\\.028407967787274342\ \(0\)\
\-\ years\\:\\ 0\\.028334634679521787\ \(0\)\
\-\ neck\\:\\ 0\\.028276442306614417\ \(0\)\
\-\ pulmonary\\:\\ 0\\.028175600522150977\ \(0\)\
\-\ loss\\:\\ 0\\.02816129645294266\ \(0\)\
\-\ wall\\:\\ 0\\.02811853512361896\ \(0\)\
\-\ changes\\:\\ 0\\.027935800076748042\ \(0\)\
\-\ on\\:\\ 0\\.027920824910253998\ \(0\)\
\-\ appearance\\:\\ 0\\.02786660022748977\ \(0\)\
\-\ focal\\:\\ 0\\.027649050165344396\ \(0\)\
\-\ scan\\:\\ 0\\.02742412910897058\ \(0\)\
\-\ secondary\\:\\ 0\\.027398073610308195\ \(0\)\
\-\ old\\:\\ 0\\.027360832828374912\ \(0\)\
\-\ months\\:\\ 0\\.0269060518841542\ \(0\)\
\-\ fluid\\:\\ 0\\.026688663950300912\ \(0\)\
\-\ significant\\:\\ 0\\.026688663950300912\ \(0\)\
\-\ due\\:\\ 0\\.026570366183600837\ \(0\)\
\-\ anterior\\:\\ 0\\.025808726935480367\ \(0\)\
\-\ is\\:\\ 0\\.025317460359961696\ \(0\)\
\-\ physical\\:\\ 0\\.02506366190977433\ \(0\)\
\-\ increased\\:\\ 0\\.02499568934618182\ \(0\)\
\-\ upper\\:\\ 0\\.024701338476413436\ \(0\)\
\-\ associated\\:\\ 0\\.0243634637701712\ \(0\)\
\-\ tumor\\:\\ 0\\.024177783725604345\ \(0\)\
\-\ were\\:\\ 0\\.023827086910286704\ \(0\)\
\-\ present\\:\\ 0\\.02371898649715106\ \(0\)\
\-\ case\\:\\ 0\\.023222386771014524\ \(0\)\
\-\ large\\:\\ 0\\.023160470495736062\ \(0\)\
\-\ lateral\\:\\ 0\\.022939908460853607\ \(0\)\
\-\ but\\:\\ 0\\.022857792802711906\ \(0\)\
\-\ treatment\\:\\ 0\\.02201889823582987\ \(0\)\
\-\ male\\:\\ 0\\.020580660254228642\ \(0\)\
\-\ disease\\:\\ 0\\.019403152819204773\ \(0\)\
\-\ there\\:\\ 0\\.018392347982019067\ \(0\)\
\-\ from\\:\\ 0\\.01835817501370343\ \(0\)\
\-\ at\\:\\ 0\\.017459353753233132\ \(0\)\
\-\ was\\:\\ 0\\.01610948821271321\ \(0\)\
\-\ or\\:\\ 0\\.016080473151706194\ \(0\)\
\-\ year\\:\\ 0\\.014245297168956889\ \(0\)\
